DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
Abstract Background As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, development of new drugs is urgently required. Flavonoids extracted from Artemis...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-02-01
|
| Series: | Virology Journal |
| Online Access: | http://link.springer.com/article/10.1186/s12985-019-1125-9 |